BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8828625)

  • 1. Utilisation of amino acid mixtures in adolescents with phenylketonuria.
    Mönch E; Herrmann ME; Brösicke H; Schöffer A; Keller M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S115-20. PubMed ID: 8828625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
    Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate status in patients with phenylketonuria.
    Couce ML; Sánchez-Pintos P; Vitoria I; De Castro MJ; Aldámiz-Echevarría L; Correcher P; Fernández-Marmiesse A; Roca I; Hermida A; Martínez-Olmos M; Leis R
    Orphanet J Rare Dis; 2018 Jun; 13(1):103. PubMed ID: 29945661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.
    van Calcar SC; MacLeod EL; Gleason ST; Etzel MR; Clayton MK; Wolff JA; Ney DM
    Am J Clin Nutr; 2009 Apr; 89(4):1068-77. PubMed ID: 19244369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenylalanine-free amino acid mixture: metabolic effects in relation to a single dose].
    Hermann ME; Mönch E; Reinbacher M; Kohlen W; Brösicke HG
    Monatsschr Kinderheilkd; 1991 Oct; 139(10):670-5. PubMed ID: 1961204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
    MacDonald A; Singh RH; Rocha JC; van Spronsen FJ
    Nutr Res Rev; 2019 Jun; 32(1):70-78. PubMed ID: 30284526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
    Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
    Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.
    MacLeod EL; Clayton MK; van Calcar SC; Ney DM
    Mol Genet Metab; 2010 Aug; 100(4):303-8. PubMed ID: 20466571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylketonuria diet in adolescents--energy and nutrient intake--is it adequate?
    Link R
    Postgrad Med J; 1989; 65 Suppl 2():S21-4. PubMed ID: 2622814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria.
    Moretti F; Pellegrini N; Salvatici E; Rovelli V; Banderali G; Radaelli G; Scazzina F; Giovannini M; Verduci E
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):176-182. PubMed ID: 28081989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
    Ney DM; Murali SG; Stroup BM; Nair N; Sawin EA; Rohr F; Levy HL
    Mol Genet Metab; 2017 Jun; 121(2):96-103. PubMed ID: 28400091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.